Page last updated: 2024-08-22

clodronic acid and Cushing's Syndrome

clodronic acid has been researched along with Cushing's Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caggiano, F; Colao, A; De Leo, M; De Martino, MC; Guerra, E; Lombardi, G; Pivonello, R; Tauchmanova, L	1

Trials

1 trial(s) available for clodronic acid and Cushing's Syndrome

Article	Year
Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome. Journal of endocrinological investigation, 2009, Volume: 32, Issue:5 Topics: Adenoma; Administration, Oral; Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Bone Resorption; Calcium; Cholecalciferol; Clodronic Acid; Cushing Syndrome; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Spinal Fractures	2009

Article

Year

Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.

Journal of endocrinological investigation, 2009, Volume: 32, Issue:5

Topics: Adenoma; Administration, Oral; Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Bone Resorption; Calcium; Cholecalciferol; Clodronic Acid; Cushing Syndrome; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Spinal Fractures

2009